FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London.Oli Scarff | Getty ImagesThe Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older.The approval, the first ever globally by a regulatory body…